This work describes the determination of CBF in eight normal human subjects with positron emis sion tomographic (PET) imaging using the continuous in
travenous infusion of H2150. A whole-brain CBF model is described that permits the comparison of the CBF values determined using PET with those obtained using other methods. This model includes a correction for whole-brain recovery coefficient, a correction for the un derestimation of flow due to the nonlinearity of the CBF model when considering tissue that includes both gray
The measurement of CBF with positron emission tomography (PET) is a valuable adjunct to the mea surement of the cerebral metabolic rate for glucose. Of the three general types of techniques used to measure CBF-the clearance or uptake of an inert and diffusible tracer, the fractional distribution of an agent that is trapped in capillaries, and equilib rium imaging of a short-half-lived, inert, diffusible tracer-equilibrium imaging with PET has several advantages. The equilibrium model using 150 (half life 2. 07 min) (Jones et aI. , 1976; Subramanyan et aI. , 1978; Frackowiak et aI. , 1980) has been used extensively to study pathophysiology and normal physiology (Ackerman et aI., 1981; Frackowiak et aI., 1981; Baron et aI. , 1982; Ito et aI. , 1982; Lam mertsma et aI. , 1983; LeBrun-Grandie et aI. , 1983) . It has been studied theoretically and with simula tion techniques (Lammertsma et aI. , 1981b (Lammertsma et aI. , , 1982  and white matter, the use of in vitro-determined brain-blood partition coefficients for gray and white matter, and a variation of the equilibrium model that per mits the arterial concentration to vary. CBF values using this method compare well with values determined pre viously. Regional determinations using a brain overlay atlas are presented. Radiation dosimetry for the contin uous infusion of H2150 is also included. Key Words: Ce rebral blood flow-Oxygen-15-labeled water-Positron emission tomography. Jones et aI. , 1982) and has been shown to give ac curate and reasonably precise values of CBF, even though it suffers from reduced sensitivity at high flows. The equilibrium technique is well suited both to the more recent PET devices and to other PET devices with lower sensitivity. The stable activity distribution during equilibrium allows the collection of adequate count densities for minimizing statis tical effects in the reconstructed image. The advan tage of using 150 for measuring flow, instead of a longer-lived clearance tracer, is that it can also be used to measure the cerebral oxygen extraction ratio and the CMR02• Other techniques using oxygen-15-labeled water (H21 5 0) for the measurement of CBF with PET have measured the clearance or uptake of H2150 after the inhalation of oxygen-15-labeled carbon dioxide (CI502) or the bolus intravenous injection of H2150 (Huang et aI., 1983; Raichle et aI. , 1983; Kanno et aI. , 1984) . These techniques work best with the newer PET instruments with fast count rate capa bilities and high detector efficiency to obtain a sta tistically adequate number of counts, although Kanno et ai. (1984) have optimized imaging acqui sition for a relatively insensitive PET device.
Previously, the continuous inhalation of C 1 502, which is quickly converted to H2150 in the lungs, has been used for the equilibrium measurement of CBF. This report describes the initial studies in normal human subjects using the continuous intra venous infusion of H2150 to measure CBF with PET. The technique includes the use of known par tition coefficients for gray and white matter deter mined from in vitro measurements and a realistic model for evaluating whole-brain CBF (C BFwB). A variation of the equilibrium model that allows for varying arterial inputs is described. Both the equi librium technique and this nonequilibrium tech nique (NET) are used. In addition, regional indices of CBF (CBFI) are reported using a recently de veloped brain region-of-interest (ROI) overlay system (Dann et aI. , 1983) .
MATERIALS AND METHODS

Preparation of H2150 for continuous infusion
The production and transport of HZl50 vapor and the H2150 intravenous infusion system have been described previously (Jones et ai., 1984) . Briefly, oxygen-15-labeled water vapor is produced in a flowing gas target of 5% H2 and Nz using the 14N(d,n)150 reaction with 10 MeV-deu terons incident on the gas. Radio-gas chromatography using a column of Chroma sorb 104 at 130°C with a helium carrier gas is used to analyze for radiochemical impuri ties. A gas transport system consisting of 1,000 m of 3.2mm-inside diameter Te flon tubing delivers the water vapor at 5 L min -I from the accelerator target area to the site of the PETT-V tomograph. The infusion system to entrap the HZl50 vapor in saline is placed next to the subject during the imaging procedure. This infusion system consists of two saline pumps, a bubbling tube and overflow trap, and a saline radioactivity monitor. The sa line flow rate is 2 ml min -I. A terminal membrane filter (0.22 /-Lm) ensures sterility. The system satisfies electrical safety requirements, possesses a suitable appearance for operation in a medical environment, and has been shown to produce a sterile and apyrogenic solution. In summary, the production and transport of H2150 vapor and the H2150 infusion system all operate continuously and pro duce the output necessary for continuous intravenous in fusion.
CBF determination
The determination of CBF was carried out in eight normal subjects ranging in age from 18 to 27 years. Cath eters (20 gauge, 5.1 cm) were positioned in the radial artery and the opposite antecubital vein. The arterial line was kept open with a pressurized drip system and the venous line with an intravenous infusion of saline. The subject was then positioned in the PETT-V (Ter-Pogos sian et ai., 1978). The subjects had their eyes open and ears unplugged and were instructed not to go to sleep. Their position in the scanner was monitored with a laser alignment system (Gammex, Inc.). After positioning, an infusion of H2150 was started in the antecubital vein. Im aging began -10 min later and continued for 10-31 min. Approximately 2 x 106 counts were collected per slice. The administered activity expressed as the rate-duration product (delivery rate in mCi min-I times duration in min) was between 39 and 67 (mCi min-I) (min). After the head coincidence rate, as determined by monitoring the coincidence count rate of the PETT-V, had plateaued, arterial samples were taken every 3-4 min for analysis of the 150 concentration in whole blood. In the last two studies samples were taken every 2 min during the first 10 min and every 3-4 min for the remainder of the study. Arterial blood gases and pH were determined at the be ginning and end of the imaging period. Blood samples were counted within 4--7 min after withdrawal and the activities were corrected for decay. Previously, the PETT -V had been calibrated with a six-segment pie phantom filled with varying concentrations of 68Ga. 68Ga is used without correcting for positron emission rate. The blood samples were counted in the same counter as sam ples from this pie phantom to allow blood and tissue ac tivity to be expressed in equivalent units. Attenuation correction was performed by calculation after the head position was determined by positioning an ellipse over the image of the brain using the 50% intensity level as a guide.
Radiation dosimetry estimates are calculated and pre sented in the Appendix.
Human subjects were studied under the guidelines es tablished by the institutional Human Studies Committee and the U.S. Food and Drug Administration.
CBFwB calculation
For the measurement of CBF using PET and HZl50 infusion, the working equation for the equilibrium tech nique as described by Subramanyan et ai. (1978) or the NET equation was used. Modifications were made to ob tain the average CBF for the whole brain. These modi fications included a correction for the recovery coeffi cient (Hoffman et ai., 1979) of whole brain and a term to account for the effect of averaging gray and white matter (Lammertsma et ai., 1981a) . The addition of the recovery coefficient to the model for CBFwB is necessary because of the finite spatial resolution of the PETT-V tomograph [1.7 cm full width at half-maximum (FWHM)]. This term corrects for the number of counts that are lost after the placement of an ROI around the whole brain. It was ap proximated by placing a large ROI to obtain the total counts from the whole brain. A ROI was then placed around the 50% intensity level to define the area of the whole brain in a slice. With normal distribution of activity the 50% intensity level corresponds well with the brain area measured by nuclear magnetic resonance (NMR) with the ratio of 50% areaiNMR area = 0.99 ± 0.08 (Chawluk et ai., 1984) . The area of the ventricles (5% of the brain area) was not subtracted from the brain area. The effective count density was then calculated from the total counts divided by the area of the brain. This method of correction for the effect of the recovery coefficient was compared with measurements of the recovery coefficient of both a cylindrical phantom and a head phantom filled with a uniform activity solution. These measurements in phantoms correlated well with the measurements of the recovery coefficient in normal subjects using the above technique as shown in Ta ble 1.
Because the relationship between brain tissue concen tration and flow using the equilibrium model is nonlinear, an underestimate of CBF results when both gray and white matter are included in the same ROI. For the de termination of CBFwB, the amount of this underestima tion can be calculated using several assumptions (Lam·· mertsma et ai., 1981a) . With the assumptions of a 4:1 Recovery coefficient for subjects and the head phantom was computed by dividing the counts in the area defined using the 50% intensity level by the total counts in the image. For the cylindrical phantom, the area used was the actual area of the cylinder.
; � I where A; and k; are the coefficients and the rate constants of the fitted arterial curve, is substituted for the arterial concentration in this conservation of mass equation. In stead of setting the differential term equal to zero to ob tain the equilibrium solution, the equation is solved ex plicitly. This leads to an expression for the brain tissue concentration as a function of time
This expression is then integrated over the PET data col lection time interval to obtain an expression for the av erage brain concentration Ct that is determined from PET.
Thus, this method is a double-integral method.
The solution for Ct is given by
ratio of gray to white matter flow, a mean flow of 50 ml 100 g-I min -I, and a 50:50 mix of gray and white matter, this correction factor, M, is 0.83. Separate partition coef ficients for gray and white matter are used to calculate M. However, the effect of bone and ventricles was not included. This factor is relatively insensitive to the gray-white matter ratio in the range between a 40:60 and 60:40 mix, varying from 0.80 to 0.85 or by 6% over this range.
M is also insensitive to changes in the assumed mean flow. For a 25% change in mean flow, the value of M changes by only 2%. Thus, for a change in mean flow from 50 to 63 ml 100 g-I min -I, M changes from 0.830 to 0.815.
The working equation using the equilibrium model for calculating CBFwB is
wherefis the CBF (ml g-I min -I), A is the decay constant of 150 (min -I), Ca is the mean arterial 150 concentration in whole blood (nCi ml-I), Ct is the average brain 150 concentration for one slice determined as described above (corrected for the effect of recovery coefficient) (nCi ml-I), Pm is the mean brain-blood partition coeffi cient for water (0.91 ml g-I) (Herscovitch and Raichle, 1985) , D is the brain density (1.04 g ml-I), and M is the gray-white matter mixture correction term as described above. For the NET model a working equation for CBF was used that permits a nonstable arterial and brain concen tration (Greenberg et al., 1984) . The conservation of mass equation that is the basis for the equilibrium technique is the starting point of this derivation. This equation is 1985 where TI is scan start time and T2 is scan end time. A look-up table is generated from this equation for obtaining CBF from Ct.
In practice, no more than three exponentials have been used to fit the arterial curve using least-squares minimi zation. The fitted arterial curve compared well with the time course information from the head coincidences ob tained from the PETT-V bank coincidence rate.
CBFwB was corrected for CO2 sensitivity using a per centage sensitivity of 2.7% mm Hg-I (Ackerman et aI., 1973) .
Comparison of the equilibrium and NET models
In four studies, the equilibrium and NET models were compared. For these subjects, the arterial concentration variability (coefficient of variation) (COV) and change (percentage difference between the first and last arterial sample normalized to 15 min) during the period of the PET data collection were <15 and 20%, respectively. These limits were chosen based on the comparison of how much the NET analysis actually changed the results. For a 20% change in arterial concentration over a period of 15 min, a 4% change in CBF is introduced by using the NET analysis.
Regional CBFI determination
Six anatomical areas were analyzed using ROI overlays as described by Dann et al. (1983) . The overlays were superimposed on the scan images and were aligned with the images using the outside edge of the brain and midline as landmarks. Anatomical symmetry of the brain was as sumed. The ROIs were then automatically scaled using this information. This system was used to eliminate vari ability in the placement of ROIs. By choosing to analyze the data in this rigidly defined manner we avoid the ten-dency to place ROIs in the highest-and lowest-activity areas to obtain high and low values of CBF. This tech nique produces homologous ROIs in each hemisphere, permitting side-to-side differences to be assessed. Over lays were positioned over three to four slices of the brain with each anatomical structure being identified in from one to three slices so that an average CBFI was computed for each subject. In general, the ROIs are small enough that the contamination of gray matter with white matter and vice versa is minimized.
By placing the ROI overlays on digitalized images of brain tissue sections, it was determined that a typical gray matter ROI includes 10-30% white matter. This causes an underestimation in gray matter CBFI of from 7 to 18%.
Regional CBFIs from anatomical ROIs were deter mined with the partition coefficient for either gray or white matter being used, depending on the definition of the structure. The partition coefficient of 0.84 ml g-I was used for white matter and 1.00 ml g-l for gray matter. These values were determined from the water content of blood and brain (Jones et aI., 1982) and then corrected for the density of the brain (Herscovitch and Raichle, 1985) .
RESULTS
Comparison of the equilibrium and NET models
The comparison between the two methods of analysis is presented in Ta ble 2. In the four subjects (nos. 2, 3, 7, and 8) that fulfilled the criteria for comparison, the means and standard deviations are essentially equivalent. For this reason, the NET analysis was used for all the subjects.
CBFwB values
The arterial time course and head coincidence rate are shown for two studies in Fig. 1 . CBFwB values for the eight subjects are presented in Ta ble 3. These values are the mean of three slices from each subject and are corrected for recovery coeffi cient, for the underestimation of the model due to gray-white mixing, and finally for CO2 sensitivity. The range of CBFwB was 47-77 ml 100 g-I min-I, with a mean of 62 ± 13 ml 100 g-I min -I (± SD). The mean (± SD) Paco2 for these subjects was 41 ± 2. 0 mm Hg.
Regional values of CBFI Regional values of CBFI were analyzed in four gray and two white matter areas (Table 4) . Average gray matter flows varied from 39 to 46 ml 100 g-I min -I depending on ROI size and the proximity of the regions to the edge of the brain, ventricles, or white matter. CBFs from each structure were ob tained in at least seven subjects. White matter flows were 31 and 28 ml 100 g -I min -I in the centrum semiovale and parietal white matter, respectively.
DISCUSSION
Previously, the continuous inhalation of CI502 has been used in the equilibrium imaging for CBF with PET. The continuous infusion of H2150 pro vides a number of advantages. First, the inhalation of CI502 results in a large amount of airborne ra dioactivity in the nasopharynx and upper airways, which contributes to scattered and random coinci dences during the imaging procedure. Because H2150 is introduced intravenously in a peripheral vein, this source of radioactivity near the field of view of the imaging instrument is not present with our technique. The elimination of this complicating factor leads to increased data rate capabilities and less uncertainty due to random and scatter correc tion. Second, the stability of the CI502 inhalation is subject to variations in the subject's breathing pat terns, whereas with the intravenous infusion of H2150, ventilatory parameters are of no concern. The intravenous infusion of H2150 can be accom plished in patients who are comatose or uncooper ative or who are in respiratory distress.
Radiation dosimetry
One of the major advantages of the infusion of H2150, instead of the inhalation of C1502, is that the radiation dose to the lungs is reduced. Using the same assumptions to calculate the radiation dose to the lungs for a CI502 inhalation study, one can show that the dose to the lungs for the water infusion technique is 12% of that for a Cl502 inhalation study. This allows either the radiation dose to the subject to be reduced with no decrease in the sta tistical accuracy of CBF or the number of counts data collection started at 8 min and ended at 30 min for subject no. 2 and at 12 and 25 min, respectively, for subject no. 8. The coefficient of variation in the arterial concentration during data collection was 4% for subject no. 2 and 8% for subject no. 8. The arterial concentration was sampled more frequently during the interval between the start of infusion and image acquisition. obtained in a given tomographic slice to be in creased at the same radiation dose. This increased number of counts can be used to compensate, up to a limit (Lammertsma et aI., 1982) , for the in herent loss of sensitivity in the equilibrium model at high flows by decreasing the uncertainty in flow due to the statistics of radioactive decay.
Another advantage of the H2150 infusion tech nique in comparison to CI502 inhalation is that ra diation dose to the tracheal mucosa is avoided. In haled CI502 has been shown to result in a large amount of radioactivity on the mucosal surfaces of the large airways and trachea (Powell et aI., 1984a,b) . This radioactivity, presumably from HPO produced from the inhaled C1502, results in very high local radiation doses to the mucosal sur faces of the nasopharynx and trachea. These doses range from 60 to 250 rads for a typical CI502 inha lation study (Powell et aI. , 1984a,b) , although these J Cereb Blood Flow Metabol , Vol. 5, No.4, 1985 data concerning high tracheal doses have been re cently challenged (J. A. Correia, personal commu nication). The H2150 infusion does produce a local high ra diation dose to the infusion site. The dose to the infusion site is estimated in the Appendix to be 17 rads for the rate-duration product of 80 (mCi min -I) (min). This is within the regulatory limit for a dose to an extremity of 75 rads. In addition, if this dose is averaged by weight over the whole extremity, as is permitted by regulatory practice, it is reduced in proportion to the fractional mass of the extremity that receives this dose. If need be, this local radia tion dose could be decreased further by advancing the infusion catheter into a larger vein with a greater flow rate.
It is appropriate to compare the infusion site dose for the continuous infusion of H2150 with that when H2150 is introduced as a bolus. For the radiation dose to the vein wall, the amount of activity that is injected as a bolus is equivalent to the rate-duration product for continuous infusion. Activities used in the bolus techniques range from 50 (Huang et aI. , 1983) to 82 (Raichle et aI. , 1983) mCi and are slightly higher than the activities used for this technique [(39-67 mCi min-I) (min)]. Of course, the amount Values are means (SE) for n = 8 except for anterior calcarine cortex (n = 7). and rate of ISO administration are dependent on such factors as the CBF model and the design of the tomograph.
The radiation dose estimates of Kearfott (1982) for H2150 infusion compare well with our estimates for the organs presented in Ta ble 5, except for brain where a value 77% less than the value in this study was obtained. As discussed in the Appendix, the brain radiation dose estimated here is an overesti mate. Comparison of the results is not possible be cause the assumptions used in the calculations are not available.
CBF W B
For the calculation of CBFwB values, the equilib rium and NET models were modified to include the effects of recovery coefficient on a whole-brain ROI and the effect of the underestimation of the model due to gray and white matter mixing. This allows the comparison of the whole-brain values from this study with values using other more established techniques for determining CBFwB.
Ta ble 6 presents a comparison of the mean CBFwB values obtained in this study with the mean CBF values in 14 normal individuals obtained by Kety and Schmidt (1948) using the inhalation of ni trous oxide and arterial and jugular vein sampling. The mean value (± SD) for this study of 62 ± 13 ml 100 g -I min -I compares well with their value of 54 ± 12 ml l 00 g-I min-I.
Inaccuracies in the measurement of CBFwB can be attributed to errors in PET and blood sample counter cross calibration, errors in the measure ment of Ca and in arterial sampling, or errors in the measurement of ISO brain concentration Ct. Since samples from the pie phantom were counted in the same well counter as blood samples, cross calibra tion errors were minimal. : Calculated with absorbed fractions (Snyder et aI., 1969) .
Estimated to be less than or equal to total body dose. Values are expressed as ml 100 g -I min -I . a See Kety and Schmidt (1948) .
Errors in Ca due to volume measurement errors were minimized by calibrating the pipettes gravi metrically with whole blood. The reproducibility of the volume determination is 1. 5% (SD). Errors in Ca due to the delay time correction between arterial sa � ple withdrawal and counting were minimized by usmg a gamma-counter with an internal clock syn chronized to the study stopwatch to within 1 s. A I-s error in delay time gives a 0. 56% error in the decay correction and a 0. 72% error in CBF. Counting statistics are not a major source of error in Ca because at least 20,000 counts were accumu lated, giving an SD of <1% in counting statistics.
Errors in the determination of the mean value of Ca, if the equilibrium model is used, or errors in fitting a curve to discrete arterial samples, if the NET model is used, affect the determination of CBFwB. For the equilibrium studies, multiple arte rial samples were taken and averaged to obtain the mean arterial concentration during the PET study. The COY for these samples was between 4 and 12%. Meyer and Yamamoto (1984) have estimated that errors in Ca from sampling artifacts are mini mized if the average from multiple arterial samples is used.
Errors in the measurement of Ct are due to atten uation correction and recovery coefficient errors.
The assumption that the 50% intensity level repre sents the edge of the head is used in both of these procedures. Also, the effect of bone and ventricles is not included in the attenuation correction and recovery coefficient. As these assumptions were used uniformly in our data analysis, one would ex pect that any systematic errors involved would not increase the COV, but would affect only the accu racy of the mean value of CBF. If an error of 2-3% in Ct could be attributed to these combined proce dures, an error of 6-10% would result in CBF. This is probably one of the major sources of error in this procedure.
The variation in CBF due to different arterial ten sions of CO2 did not affect the variability of CBF .
smce t e su �ect-to-subject variability of P aco2 was small and the CBF was corrected to a mean P co a 2 of 40 mm Hg.
One factor that should be considered is the prop-agation of error through the working equation of the equilibrium and NET models. The COY in the mean CBFwB is 21%. The ratio of the COY in CBF to the COY in C/Ca is �2. 5 for a mean flow of 55 ml 100 g-I min -I for the equilibrium technique (Jones et aI. , 1982) or for the NET (Greenberg et aI., 1984) . Thus, a calculated COY of 21% in CBF results from the COY of 8% in the ratio C/Ca. This is a reason able degree of accuracy when all of the factors that are used in the measurement of Ct and Ca are con sidered. Some of this variation is due to normal physiological variability.
Regional CBFI Individual brain-blood partition coefficients for gray and white matter were used to calculate re gional CBFIs. The variability in the brain-blood partition coefficient calculated from the known amounts of water in brain and blood is quite small. The COY is � 1.7% for both of these partition coef ficients. There is inevitable contamination of gray matter ROIs with white matter and of white matter ROIs with gray matter due to the 1.7-cm FWHM spatial resolution of the PETT -V. This is minimized by careful and reproducible positioning of anatom ically defined ROIs.
The effect on CBFI of white matter contamina tion in a gray matter ROI is shown in Fig. 2 . This figure is a theoretical plot of the correction factor in CBFI as a function of percentage white matter contamination. Using this correction factor, the un derestimation that the gray-white matter admixture causes in the determination of regional CBFI using the equilibrium and NET models can be estimated if the amount of white matter contamination in rep- FIG. 2. The CBF correction factor is plotted as a function of the amount of white matter contamination in a gray matter structure region of interest (ROI). By dividing this correction factor into the CBF obtained in a gray matter ROI, the CBF is corrected for the underestimate due to gray-white matter admixture. For a gray matter structure ROI that was contam inated with 10% white matter, the CBF index would be un derestimated by (1 -0.93) or 0.07. Vol. 5, No.4, 1985 resentative gray matter ROIs can be measured. For instance, using the brain specimens for the overlay atlas, the lenticular nucleus ROI was shown to con tain an average of 90% gray matter and 10% white matter. For this 10% contamination, the CBF cor rection factor is 0.93; thus, CBFI would be in creased by �7%. This is in contrast to the analysis of Herscovitch and Raichle (1983) where larger er rors were estimated, presumably because of dif ferent assumptions concerning the value of the parti tion coefficient for regional CBF. The gray-white matter flow ratio for the CBFI is 1. 4: 1. This value is less than the actual 4: 1 ratio because of the finite spatial resolution of the to mograph. To obtain a ratio that is closer to the 4:1 value a tomograph with a higher spatial resolution could be used.
The strategy used here for the measurement of regional CBFI is to knowingly ignore the effect of the object size and instrument resolution (Hoffman et aI. , 1979; Mazziota et aI., 1981 ) on brain concen tration in the regional ROIs. The ROIs were gen erated using a standard atlas overlay system that was created from human brain slices at the same angle as was actually used for data collection. The recovery coefficient is highly dependent on the size of the ROI chosen for the anatomical structure and the values of CBF in the surrounding areas. There fore, estimation of these factors is not possible. In this light, these values represent regional CBFIs. If they could be corrected for object size, gray matter areas would produce higher values of CBF and white matter areas, lower values. Even though these values of CBFI are indices, they can be com pared with other physiological variables (such as metabolism) in the same ROIs. The correction for object size would be identical if surrounding values for the tissue concentrations used to determine the other physiological variable were similar.
Comparison of the equilibrium and NET models
The equilibrium and NET models give similar re sults when used on subjects that satisfy the strict requirements for an equilibrium study. Often the ar terial concentration of 150 will change in an equi librium study using CJ50Z inhalation or HZl50 in fusion. However, using the NET model, the data can still be analyzed as long as the PET image ac quisition operates to produce an average over time. The PETT-Y collects a complete angular and linear data set for three-dimensional reconstruction in < 1 mm.
In the HzO infusion technique, changes in arterial concentration can occur owing to changes in 150 production or delivery parameters. In the CO2 in-halation technique, changes can also occur in the arterial concentration due to changes in subject breathing patterns.
If the equilibrium model is used with an average arterial and average brain concentration, a mises timation of flow results because the assumption of equilibrium is no longer valid. By using an analysis similar to that of Meyer and Yamamoto (1984) , the error in CBF is <4% if the change in Ca is under 20% for a scan duration of 15 min if mUltiple arterial samples are averaged. The reason for this is that the arterial curve and the brain curve are very closely related because the brain tissue activity re sponds quickly to a change in the arterial input. If sequential arterial samples and the coincidences in one bank pair of the PETT -V are plotted against time, it is noted that small fluctuations in the arterial input function are most often "tracked" by similar changes in the head activity curve. This is quite reasonable, as the rate constant for this system is A + f/P m' For a flow of �50 ml too g� I min � I, this rate constant is 0.88 min � I (0.335 + 0.510.91).
Thus, in three time constants [3/(A + f/P m)] or 3.4 min, the brain concentration has reached 95% of its equilibrium value. The brain activity responds rel atively quickly to a slowly changing arterial con centration curve.
When the arterial concentration drifts >20% per 15 min, errors introduced by the assumption of equilibrium grow larger. In the comparison of the equilibrium and NET models, only studies where the change in Ca was less than this limit were used.
The NET model, which does not assume equilib rium conditions in arterial or brain concentrations and which gives the same result as the equilibrium model for equilibrium studies, was used for this work.
CONCLUSION
The continuous infusion of H2150 represents an alternative to the continuous inhalation of CI502 for determining CBF with equilibrium imaging and PET. The advantages of using continuous H2150 in fusion instead of CI502 inhalation are the lower ra diation dose to the lung and mucosal surfaces of the nasopharynx and large upper airways, the elimina tion of a source of scattered radiation, and the ease of intravenous administration. In relation to the H2150 bolus injection techniques, the continuous in fusion of H2150 keeps whole-body 150 activity at a lower and more constant level and permits the use of PET instruments that do not have high count rate capabilities. The advantage of using 150 instead of longer-lived clearance tracers is that the oxygen ex-traction ratio, and therefore CMR02, can be deter mined in the same setting sequentially. Other flow techniques do not have this immediate applicability to the measurement of regional oxygen metabolism.
In summary, we have obtained CBFwB values that agree well with established techniques. Re gional CBFIs can be compared with other physio logical variables in the same anatomical areas. In addition, strict equilibrium is not required if the NET model is used, although this modification can be utilized equally well with the CI502 inhalation equilibrium technique.
APPENDIX
Radiation dose estimates to organs
The absorbed radiation dose for a CBF study with H2150 infusion as estimated using the absorbed fraction technique as described by Snyder et al. (1975) and implemented in a software package called CAMIRD III (Bellina and Guzzardi, 1980) . S values for the brain were calculated from absorbed fractions (Snyder et al., 1969) and the reciprocity theorem. The cumulated activities for input to this software package are calculated as described below.
The cumulated activity of the total body AB (in /-LCi h) is given by the product of the total equilib rium activity Rb/A and the total infusion time Tj (min):
where Rb and A are the infusion rate (/-LCi min � I) and the decay constant of 150 (20 h � I) respectively. This expression assumes that the delivery and decay of activity proceed at the same rate.
The cumulated activity for the kth target organ is
where W k refers to mass and F k refers to the frac tional water space (Vennart, 1969) of the source tissue k and W B and F B refer to mass and fractional water space of the whole body, respectively. This expression assumes that 150 is distributed ac cording to water volume, an assumption that is useful for the calculation of radiation dose.
Radiation doses are calculated for an infusion rate-duration product of 80 (mCi min --I) (min).
Radiation dosimetry estimates for H2150 infusion for an infusion rate-duration product of 80 (mCi min � 1) (min) for a 70-kg person range from 130 to 200 mrads for the various organs (Table 5) . A value of 204 mrads for the brain is an overestimate since the S values were not corrected for the activity in the other organs. The approximately equivalent ra diation doses to the various organs are due to H2150 not being concentrated in any particular organ or organ system. If H2150 were introduced via CI502 inhalation, the lungs would have received a larger radiation dose.
Infusion site radiation dose estimate
The radiation dose to the infusion site can be es timated in the following way. Assuming a blood flow velocity of 600 cm min -I (Watanbe et aI., 1984) through the antecubital vein with a radius of 0.15 cm, the volumetric flow rate (internal cross-sec tional area times velocity) is 3.14 (0.15) 2 600 = 42 ml min -I. For an infusion rate of 1 mCi min -I, the concentration at the infusion site would be 1,000/42 = 24 !LCi ml-I. With the 150 positron equilibrium dose constant of 1.5 g rad !LCi -I h -I, and making the assumption that the radiation dose at the vein wall is one-half that in the center of the lumen, the dose rate would be (1.512) x 24 = 18 rad h-I for an infusion rate of 1 mCi min -I. For a maximum rate-duration product of 80 (mCi min -I) (min) as used in this study, the radiation dose would be 18 x 80/60 = 24 rad. This estimate does not consider the finite range of the positron in relation to the internal diameter of the vein. If 30% of the 150 pos itron energy is lost (assuming an average distance of 1 mm) (Berger, 1971) , then the radiation dose would be (1 -0.3) x 24 = 17 rads for the rate-duration product of 80 (mCi min -I) (min).
